Bright Minds Biosciences DRUG
NASDAQ DRUG
$50.04 +0.83 (+1.69%)
As of: Oct 2, 2026 · 10:25 AM EDT

Bright Minds Biosciences (DRUG) Tax Provisions (2025)

Updated

Bright Minds Biosciences (DRUG) reported Tax Provisions of -$187,377 for fiscal Q4 2025 (quarter ended Sep 30, 2025).

Analysis

Bright Minds Biosciences (DRUG) Tax Provisions (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.21 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 662.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 654.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -1.01 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -291.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 393.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 242.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -407.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 292.00 Mn
10 Bright Minds Biosciences 380.42 Mn 380.42 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -187,376.64
Jun 30, 2025 186,107.28
API Access

Bright Minds Biosciences Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=DRUG&period=max&api_key=YOUR_API_KEY